Firestein & Kelley's Textbook of Rheumatology, 2-Volume Set
Editat de Gary S. Firestein, Iain B McInnes, Gary Koretzky, Ted Mikuls, Tuhina Neogi, James R. O'Dellen Limba Engleză Hardback – oct 2024
Preț: 1964.15 lei
Preț vechi: 2889.42 lei
-32% Nou
Puncte Express: 2946
Preț estimativ în valută:
375.86€ • 397.07$ • 314.24£
375.86€ • 397.07$ • 314.24£
Carte disponibilă
Livrare economică 05-19 decembrie
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9780323935401
ISBN-10: 0323935400
Pagini: 2400
Ilustrații: 1200
Dimensiuni: 216 x 276 x 106 mm
Greutate: 0.45 kg
Ediția:12
Editura: Elsevier
ISBN-10: 0323935400
Pagini: 2400
Ilustrații: 1200
Dimensiuni: 216 x 276 x 106 mm
Greutate: 0.45 kg
Ediția:12
Editura: Elsevier
Cuprins
VOLUME I
1 Developmental Biology, Organization, and Function of the Synovial Joints
2 Synovium
3 Cartilage and Chondrocytes
Development and Biology of Bone
5 Muscle Anatomy, Physiology, and Biochemistry
6 Biomechanics
7 Regenerative Medicine and Tissue Engineering
8 Proteinases and Matrix Degradation
9 Dendritic Cells
10 Mononuclear Phagocytes
11 Neutrophils
12 T Lymphocytes
13 B Cells
14 Fibroblasts and Fibroblast-like Synoviocytes
15 Mast Cells and Basophils
16 Innate Lymphoid Cells and Natural Killer Cells
17 Platelets and Megakaryocytes
18 Principles of Signaling
19 Innate Immunity
20 Adaptive Immunity
21 Immune Tolerance and Autoimmunity
22 Pre-clinical Autoimmunity
23 The Microbiome in Rheumatic Diseases
24 Genetics of Rheumatic Diseases
25 Epigenetics of Rheumatic Diseases
26 Complement System
27 Prostaglandins, Leukotrienes, and Related Compounds
28 Angiogenesis
29 Cytokines and Chemokines
30 Neuronal Mechanisms of Pain and Inflammation
31 Clinical Research Methods in the Rheumatic Diseases
32 Epidemiology and Impact of Rheumatic Diseases
33 Assessment of Health Outcomes
34 Biomarkers in Rheumatology
35 Occupational, Environmental, and Recreational Musculoskeletal Disorders
36 Cardiovascular Risk in Inflammatory Rheumatic Disease
37 Cancer Risk in Rheumatic Diseases
38 Occupational Therapy, Physical Therapy, and Rehabilitation
39 General Principles of Pregnancy and Rheumatic Disease: Pre-pregnancy Assessment
40 History and Physical Examination of the Musculoskeletal System
41 Ultrasound in Rheumatology
42 Evaluation of Monoarticular and Polyarticular Arthritis
43 Skin and Rheumatic Diseases
44 The Eye and Rheumatic Diseases
45 Neck Pain
46 Shoulder Pain
47 Low Back Pain
48 Hip and Knee Pain
49 Foot and Ankle Pain
50 Hand and Wrist Pain
51 Temporomandibular Joint Disorders
52 Fibromyalgia
53 Synovial Fluid Analyses, Synovial Biopsy, and Synovial Pathology
54 Arthrocentesis and Injection of Joints and Soft
Tissues
55 Anti-nuclear Antibodies
56 Autoantibodies in Rheumatoid Arthritis
57 Acute Phase Reactants
58 Imaging in Rheumatic Diseases
VOLUME II
59 Therapeutic Targeting of Prostanoids
60 Glucocorticoid Therapy
61 Traditional DMARDs: Methotrexate, Leflunomide, Sulfasalazine, Hydroxychloroquine, and Combination Therapies
62 Immunosuppressive Drugs
63 Anti-cytokine Biologics
64 Cell-Targeted Biologics and Emerging
Targets: Rituximab, Abatacept, and Other Biologics
65 Janus Kinase and Other Intra-cellular Targets
66 Urate-Lowering Therapy
67 Bisphosphonates
68 Analgesic Agents in Rheumatic Disease
69 Nutrition and Rheumatic Diseases
70 Etiology of Rheumatoid Arthritis
71 Pathogenesis of Rheumatoid Arthritis
72 Clinical Features of Rheumatoid Arthritis
73 Treatment of Rheumatoid Arthritis
74 Sjögren’s Syndrome
75 Classification and Epidemiology of Spondyloarthritis
76 Axial Spondyloarthritis
77 Reactive Arthritis
78 Psoriatic Arthritis
79 Inflammatory Bowel Disease-Associated Arthritis and Other Enteropathic Arthropathies
80 Etiology and Pathogenesis of Systemic Lupus Erythematosus
81 Clinical Features of Systemic Lupus Erythematosus
82 Treatment of Systemic Lupus Erythematosus
83 Antiphospholipid Syndrome
84 Etiology and Pathogenesis of Systemic Sclerosis
85 Clinical Features and Treatment of Scleroderma
86 Inflammatory Diseases of Muscle and Other Myopathies
87 Overlap Syndromes
88 Classification and Epidemiology of Systemic Vasculitis
89 Giant Cell Arteritis, Polymyalgia Rheumatica, and Takayasu’s Arteritis
90 Anti-neutrophil Cytoplasmic Antibody-Associated Vasculitis
91 Polyarteritis Nodosa
92 Immune Complex-Mediated Small Vessel Vasculitis
93 Primary Central Nervous System Vasculitis
94 Behçet’s Disease
95 Pathogenesis of Inflammasome-Mediated Diseases
96 Etiology and Pathogenesis of Hyperuricemia and Gout
97 Clinical Features and Treatment of Gout
98 Calcium Crystal Disease: Calcium Pyrophosphate Deposition Disease and Basic Calcium Phosphate-Associated Syndromes
99 Familial and Nonfamilial Autoinflammatory Syndromes
100 Etiology and Pathogenesis of Osteoarthritis
101 Clinical Features of Osteoarthritis
102 Treatment of Osteoarthritis
103 Metabolic Bone Disease
104 Proliferative Bone Diseases
105 Osteonecrosis
106 Relapsing Polychondritis
107 Heritable Diseases of Connective Tissues
108 Etiology and Pathogenesis of Juvenile Idiopathic Arthritis
109 Clinical Features and Treatment of Juvenile Idiopathic Arthritis
110 Childhood-Onset Systemic Lupus Erythematosus, Drug-Induced Lupus in Children, and Neonatal Lupus
111 Juvenile Dermatomyositis, Scleroderma, and Vasculitis
112 Bacterial Arthritis
113 Lyme Disease
114 Mycobacterial Infections of Bones and Joints
115 Fungal Infections of Bones and Joints
116 Rheumatic Manifestations of Human Immunodeficiency Virus Infection
117 Viral Arthritis
118 Rheumatic Fever and Post-streptococcal Arthritis
119 COVID-19 and Rheumatic Disease
120 Vaccination in Rheumatic Disease
121 Amyloidosis
122 Sarcoidosis
123 Hemochromatosis
124 Hemophilic Arthropathy
125 Rheumatic Manifestations of Hemoglobinopathies
126 IgG4-Related Disease
127 Arthritis Accompanying Endocrine and
128 Rheumatic Paraneoplastic Syndromes and Malignancies With Rheumatic Manifestations
129 Tumors and Tumor-like Lesions of Joints and Related Structures
130 Autoimmune Complications of Immune Checkpoint Inhibitors for Cancer
1 Developmental Biology, Organization, and Function of the Synovial Joints
2 Synovium
3 Cartilage and Chondrocytes
Development and Biology of Bone
5 Muscle Anatomy, Physiology, and Biochemistry
6 Biomechanics
7 Regenerative Medicine and Tissue Engineering
8 Proteinases and Matrix Degradation
9 Dendritic Cells
10 Mononuclear Phagocytes
11 Neutrophils
12 T Lymphocytes
13 B Cells
14 Fibroblasts and Fibroblast-like Synoviocytes
15 Mast Cells and Basophils
16 Innate Lymphoid Cells and Natural Killer Cells
17 Platelets and Megakaryocytes
18 Principles of Signaling
19 Innate Immunity
20 Adaptive Immunity
21 Immune Tolerance and Autoimmunity
22 Pre-clinical Autoimmunity
23 The Microbiome in Rheumatic Diseases
24 Genetics of Rheumatic Diseases
25 Epigenetics of Rheumatic Diseases
26 Complement System
27 Prostaglandins, Leukotrienes, and Related Compounds
28 Angiogenesis
29 Cytokines and Chemokines
30 Neuronal Mechanisms of Pain and Inflammation
31 Clinical Research Methods in the Rheumatic Diseases
32 Epidemiology and Impact of Rheumatic Diseases
33 Assessment of Health Outcomes
34 Biomarkers in Rheumatology
35 Occupational, Environmental, and Recreational Musculoskeletal Disorders
36 Cardiovascular Risk in Inflammatory Rheumatic Disease
37 Cancer Risk in Rheumatic Diseases
38 Occupational Therapy, Physical Therapy, and Rehabilitation
39 General Principles of Pregnancy and Rheumatic Disease: Pre-pregnancy Assessment
40 History and Physical Examination of the Musculoskeletal System
41 Ultrasound in Rheumatology
42 Evaluation of Monoarticular and Polyarticular Arthritis
43 Skin and Rheumatic Diseases
44 The Eye and Rheumatic Diseases
45 Neck Pain
46 Shoulder Pain
47 Low Back Pain
48 Hip and Knee Pain
49 Foot and Ankle Pain
50 Hand and Wrist Pain
51 Temporomandibular Joint Disorders
52 Fibromyalgia
53 Synovial Fluid Analyses, Synovial Biopsy, and Synovial Pathology
54 Arthrocentesis and Injection of Joints and Soft
Tissues
55 Anti-nuclear Antibodies
56 Autoantibodies in Rheumatoid Arthritis
57 Acute Phase Reactants
58 Imaging in Rheumatic Diseases
VOLUME II
59 Therapeutic Targeting of Prostanoids
60 Glucocorticoid Therapy
61 Traditional DMARDs: Methotrexate, Leflunomide, Sulfasalazine, Hydroxychloroquine, and Combination Therapies
62 Immunosuppressive Drugs
63 Anti-cytokine Biologics
64 Cell-Targeted Biologics and Emerging
Targets: Rituximab, Abatacept, and Other Biologics
65 Janus Kinase and Other Intra-cellular Targets
66 Urate-Lowering Therapy
67 Bisphosphonates
68 Analgesic Agents in Rheumatic Disease
69 Nutrition and Rheumatic Diseases
70 Etiology of Rheumatoid Arthritis
71 Pathogenesis of Rheumatoid Arthritis
72 Clinical Features of Rheumatoid Arthritis
73 Treatment of Rheumatoid Arthritis
74 Sjögren’s Syndrome
75 Classification and Epidemiology of Spondyloarthritis
76 Axial Spondyloarthritis
77 Reactive Arthritis
78 Psoriatic Arthritis
79 Inflammatory Bowel Disease-Associated Arthritis and Other Enteropathic Arthropathies
80 Etiology and Pathogenesis of Systemic Lupus Erythematosus
81 Clinical Features of Systemic Lupus Erythematosus
82 Treatment of Systemic Lupus Erythematosus
83 Antiphospholipid Syndrome
84 Etiology and Pathogenesis of Systemic Sclerosis
85 Clinical Features and Treatment of Scleroderma
86 Inflammatory Diseases of Muscle and Other Myopathies
87 Overlap Syndromes
88 Classification and Epidemiology of Systemic Vasculitis
89 Giant Cell Arteritis, Polymyalgia Rheumatica, and Takayasu’s Arteritis
90 Anti-neutrophil Cytoplasmic Antibody-Associated Vasculitis
91 Polyarteritis Nodosa
92 Immune Complex-Mediated Small Vessel Vasculitis
93 Primary Central Nervous System Vasculitis
94 Behçet’s Disease
95 Pathogenesis of Inflammasome-Mediated Diseases
96 Etiology and Pathogenesis of Hyperuricemia and Gout
97 Clinical Features and Treatment of Gout
98 Calcium Crystal Disease: Calcium Pyrophosphate Deposition Disease and Basic Calcium Phosphate-Associated Syndromes
99 Familial and Nonfamilial Autoinflammatory Syndromes
100 Etiology and Pathogenesis of Osteoarthritis
101 Clinical Features of Osteoarthritis
102 Treatment of Osteoarthritis
103 Metabolic Bone Disease
104 Proliferative Bone Diseases
105 Osteonecrosis
106 Relapsing Polychondritis
107 Heritable Diseases of Connective Tissues
108 Etiology and Pathogenesis of Juvenile Idiopathic Arthritis
109 Clinical Features and Treatment of Juvenile Idiopathic Arthritis
110 Childhood-Onset Systemic Lupus Erythematosus, Drug-Induced Lupus in Children, and Neonatal Lupus
111 Juvenile Dermatomyositis, Scleroderma, and Vasculitis
112 Bacterial Arthritis
113 Lyme Disease
114 Mycobacterial Infections of Bones and Joints
115 Fungal Infections of Bones and Joints
116 Rheumatic Manifestations of Human Immunodeficiency Virus Infection
117 Viral Arthritis
118 Rheumatic Fever and Post-streptococcal Arthritis
119 COVID-19 and Rheumatic Disease
120 Vaccination in Rheumatic Disease
121 Amyloidosis
122 Sarcoidosis
123 Hemochromatosis
124 Hemophilic Arthropathy
125 Rheumatic Manifestations of Hemoglobinopathies
126 IgG4-Related Disease
127 Arthritis Accompanying Endocrine and
128 Rheumatic Paraneoplastic Syndromes and Malignancies With Rheumatic Manifestations
129 Tumors and Tumor-like Lesions of Joints and Related Structures
130 Autoimmune Complications of Immune Checkpoint Inhibitors for Cancer